Tech Company Financing Transactions

AGTC Funding Round

AGTC closed a $37.5 million Series B funding round on 11/21/2012. Investors included Alta Partners, SR One Capital Management and Intersouth Partners.

Transaction Overview

Company Name

Announced On

11/21/2012

Transaction Type

Venture Equity

Amount

$37,500,000

Round

Series B

Investors

Alta Partners (Lead Investor)

SR One Capital Management (Lead Investor)

Intersouth Partners (James Rosen)

InterWest Partners (Christopher Ehrlich)

MedImmune Ventures (Samuel Wu)

Proceeds Purpose

Proceeds purposes were not disclosed.

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

14193 NW 119th Ter. 10
Alachua, FL 32615
USA

Phone

Website

Email Address

[email protected]

Overview

AGTC is developing cures for rare lung and eye diseases, offering hope to patients with unmet medical needs.

Profile

Social Media

AGTC Company Twitter Account

Company News

Facebook

AGTC on Facebook

YouTube

AGTC on YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sue Washer

Sue Washer Twitter Account

Sue Washer News

Sue Washer on Facebook

Chief Financial Officer

William Sullivan

William Sullivan Twitter Account

William Sullivan News

William Sullivan on Facebook

Chief Medical Officer

Theresa Heah

Theresa Heah Twitter Account

Theresa Heah News

Theresa Heah on Facebook

Chief Scientific Officer

Mark Shearman

Mark Shearman Twitter Account

Mark Shearman News

Mark Shearman on Facebook

VP - Bus. Development

Matthew Feinsod

Matthew Feinsod Twitter Account

Matthew Feinsod News

Matthew Feinsod on Facebook

VP - Bus. Development

Stephen Potter

Stephen Potter Twitter Account

Stephen Potter News

Stephen Potter on Facebook

VP - General Counsel

Brian Krex

Brian Krex Twitter Account

Brian Krex News

Brian Krex on Facebook

Browse more venture capital transactions:

Prev: 11/21/2012: QuaDPharma venture capital transaction
Next: 11/21/2012: Trulioo venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary